본문 바로가기

Novel Anti-Melanogenic Compounds, (Z)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico Insights

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q2
저널
MOLECULES26(16) · #4963 · 2021
피인용
Web of Science 8Scopus 10
FWCI (Scopus)
0.66
JCR IF
JCR 2020 4.412
ISSN
1420-3049

저자

  1. 최희정제1저자Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  2. 유일영Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  3. 최인규Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  4. Ullah, SultanScripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA
  5. 정희진Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  6. 박유진Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  7. 정영무Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  8. 황예지Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  9. 홍소정Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  10. 윤인수Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  11. 윤화영Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  12. 김민수Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  13. 유진욱Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  14. 정연진Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea
  15. Chun, Pusoon교신저자Inje Univ, Coll Pharm, Gyeongnam 50834, Gimhae, South Korea
  16. 문형룡교신저자Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan 46241, South Korea

초록

To confirm that the beta-phenyl-alpha,beta-unsaturated thiocarbonyl (PUSTC) scaffold, similar to the beta-phenyl-alpha,beta-unsaturated carbonyl (PUSC) scaffold, acts as a core inhibitory structure for tyrosinase, twelve (Z)-5-(substituted benzylidene)-4-thioxothiazolidin-2-one ((Z)-BTTZ) derivatives were designed and synthesized. Seven of the twelve derivatives showed stronger inhibitory activity than kojic acid against mushroom tyrosinase. Compound 2b (IC50 = 0.47 +/- 0.97 mu M) exerted a 141-fold higher inhibitory potency than kojic acid. Kinetic studies' results confirmed that compounds 2b and 2f are competitive tyrosinase inhibitors, which was supported by high binding affinities with the active site of tyrosinase by docking simulation. Docking results using a human tyrosinase homology model indicated that 2b and 2f might potently inhibit human tyrosinase. In vitro assays of 2b and 2f were conducted using B16F10 melanoma cells. Compounds 2b and 2f significantly and concentration-dependently inhibited intracellular melanin contents, and the anti-melanogenic effects of 2b at 10 mu M and 2f at 25 mu M were considerably greater than the inhibitory effect of kojic acid at 25 mu M. Compounds 2b and 2f similarly inhibited cellular tyrosinase activity and melanin contents, indicating that the anti-melanogenic effects of both were due to tyrosinase inhibition. A strong binding affinity with the active site of tyrosinase and potent inhibitions of mushroom tyrosinase, cellular tyrosinase activity, and melanin generation in B16F10 cells indicates the PUSTC scaffold offers an attractive platform for the development of novel tyrosinase inhibitors.

키워드

tyrosinasePUSTC scaffoldanti-melanogenic effectdocking simulationBIOLOGICAL-ACTIVITIESMOLECULAR DOCKINGTYROSINASEINHIBITORSSKINANTICANCERMECHANISMRHODANINESCAFFOLDDESIGN

식별자

Scopus EID
2-s2.0-85113508183
WoS UID
000690172100001